𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

✍ Scribed by Eleonor Olsson; Gabriella Honeth; Pär-Ola Bendahl; Lao H Saal; Sofia Gruvberger-Saal; Markus Ringnér; Johan Vallon-Christersson; Göran Jönsson; Karolina Holm; Kristina Lövgren; Mårten Fernö; Dorthe Grabau; Åke Borg; Cecilia Hegardt

Book ID
115010383
Publisher
BioMed Central
Year
2011
Tongue
English
Weight
336 KB
Volume
11
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency of cells expressing CD44, a He
Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: Correlation with tumor aggressiveness
✍ Benzion Joshua; Michael J. Kaplan; Ilana Doweck; Reetesh Pai; Irving L. Weissman 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 1 views

## Abstract ## Background We previously identified by flow cytometry a Lineage‐CD44+ (Lin‐CD44+) subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma (HNSCC). We now correlate clinical and histologic factors with Lin‐CD44+ cell frequency. ## Methods Th

CD133 and CD44 are universally overexpre
CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers
✍ Junwei Chen; Tianhua Guo; Lei Zhang; Li-Xuan Qin; Samuel Singer; Robert G. Maki; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB

## Abstract Although imatinib mesylate has been a major breakthrough in the treatment of advanced gastrointestinal stromal tumors (GIST), complete responses are rare and most patients eventually develop resistance to the drug. Thus, the possibility of an imatinib‐insensitive cell subpopulation with